Cytochrome P450 in living donor liver transplantation

被引：13

作者：

Chiu, King-Wah ^{[1
]}

Nakano, Toshiaki ^{[1
]}

Chen, Kuang-Den ^{[1
]}

Hsu, Li-Wen ^{[1
]}

Lai, Chia-Yun ^{[1
]}

Huang, Ching-Yin ^{[1
]}

Cheng, Yu-Fan ^{[1
]}

Goto, Shigeru ^{[1
]}

Chen, Chao-Long ^{[1
]}

机构：

[1] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Liver Transplantat Program, Coll Med, Kaohsiung 833, Taiwan

来源：

JOURNAL OF BIOMEDICAL SCIENCE | 2015年 / 22卷

关键词：

Cytochrome P450; CYP2C19; CYP3A4; CYP3A5; MDR1; Living donor liver transplantation; Pyrosequencing; Homogenous phenomenon; ACUTE CELLULAR REJECTION; CYP2C19; GENOTYPES; GRAFT; RECIPIENTS; CYP3A5; PHARMACOKINETICS; MICRODISSECTION; POLYMORPHISMS; TACROLIMUS; EXPRESSION;

D O I：

10.1186/s12929-015-0140-4

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Cytochrome P450 metabolizes many drugs in the liver. Three genotypes of CYP2C19 with extensive, intermediate, and poor metabolizing activity, respectively, have been identified in peripheral blood of transplant recipients and new liver grafts in living donor liver transplantation (LDLT). The expression of the final genotype in liver graft biopsies depends on the donor, whereas the expression in peripheral blood mononuclear cells depends on the recipient. The metabolizing isoenzyme of the major anti-rejection agents passes through CYP3A4, CYP3A5 and MDR1, which have also been identified to have similar biological characteristics as genotype of CYP2C19 in liver tissue. Recently, pyrosequencing has been used to investigate the expressions of different genotypes in liver grafts in LDLT. This review focuses on recent findings regarding the biological expressions of the CYP2C19, CYP3A4, CYP3A5 and MRD1 genotypes in liver grafts before and after LDLT. The application of pyrosequencing may be beneficial in further research on liver transplantation. Laser capture microdissection of hepatocytes in liver grafts may be a direction for future research.

引用

页数：5

共 25 条

[1] Frequent hepatocyte chimerism in long-term human liver allografts independent of graft outcome [J].

Aini, Wulamujiang ;

Miyagawa-Hayashino, Aya ;

Ozeki, Munetaka ;

Tsuruyama, Tatsuaki ;

Tamaki, Keiji ;

Uemoto, Shinji ;

Haga, Hironori .

TRANSPLANT IMMUNOLOGY, 2013, 28 (2-3) :100-105

[2] Impact of Donor and Recipient CYP3A5 and ABCB1 Genetic Polymorphisms on Tacrolimus Dosage Requirements and Rejection in Caucasian Spanish Liver Transplant Patients [J].

Angel Gomez-Bravo, Miguel ;

Salcedo, Magdalena ;

Fondevila, Constantino ;

Suarez, Francisco ;

Castellote, Jose ;

Rufian, Sebastian ;

Antonio Pons, Jose ;

Maria Alamo, Jose ;

Millan, Olga ;

Brunet, Merce .

JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (11) :1146-1154

[3] Potential implications of CYP3A4, CYP3A5 and MDR-1 genetic variants on the efficacy of Lopinavir/Ritonavir (LPV/r) monotherapy in HIV-1 patients [J].

Berno, Giulia ;

Zaccarelli, Mauro ;

Gori, Caterina ;

Tempestilli, Massimo ;

Pucci, Luigia ;

Antinori, Andrea ;

Perno, Carlo Federico ;

Pucillo, Leopoldo Paolo ;

D'Arrigo, Roberta .

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 :68-69

[4]

Chen YP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086159, 10.1371/journal.pone.0109464, 10.1371/journal.pone.0096386, 10.1371/journal.pone.0109012, 10.1371/journal.pone.0094614]

[5] Homogeneous phenomenon of the graft when using different genotype characteristic of recipients/donors in living donor liver transplantation [J].